I fear that if the FDA continues asking them to resubmit they will run TSO3 out of cash and force them to sell thier technology at 'fire sale' prices. Have held this stock for far longer than I should have but still hopeful - for now. Either the system they developed is not as sound as I and I guess many of you think or the FDA requirements, in this case, are stringent beyond reason - or .....>